127 related articles for article (PubMed ID: 10496499)
1. Cardioversion with sotalol in selected patients with vagally and adrenergically mediated paroxysmal atrial fibrillation.
Yeşil M; Bayata S; Postaci N; Yücel O; Aslan O
Angiology; 1999 Sep; 50(9):729-33. PubMed ID: 10496499
[TBL] [Abstract][Full Text] [Related]
2. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
[TBL] [Abstract][Full Text] [Related]
4. [Atrial fibrillation and the autonomic nervous system].
Hohnloser SH; van de Loo A; Klingenheben T
Z Kardiol; 1994; 83 Suppl 5():21-7. PubMed ID: 7846942
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
Hohnloser SH; van de Loo A; Baedeker F
J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic markers of repolarization heterogeneity during dofetilide or sotalol initiation for paroxysmal atrial fibrillation.
Sauer AJ; Kaplan R; Xue J; Dorsey P; Hayes M; Shah SJ; Passman R
Am J Cardiol; 2014 Jun; 113(12):2030-5. PubMed ID: 24793679
[TBL] [Abstract][Full Text] [Related]
8. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison].
Kalusche D; Stockinger J; Betz P; Roskamm H
Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939
[TBL] [Abstract][Full Text] [Related]
9. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
[TBL] [Abstract][Full Text] [Related]
10. Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes.
Lai LP; Lin JL; Lien WP; Tseng YZ; Huang SK
J Am Coll Cardiol; 2000 May; 35(6):1434-41. PubMed ID: 10807444
[TBL] [Abstract][Full Text] [Related]
11. [The effect of sotalol hydrochloride therapy on atrial signal-averaged ECG in patients with paroxysmal atrial fibrillation].
Telichowski A; Banasiak W; Wiech K; Zeborowski J; Pieróg M; Ponikowski P; Kałka D; Lacheta W; Fuglewicz A; Telichowski C
Pol Merkur Lekarski; 1996 Nov; 1(5):303-9. PubMed ID: 9273201
[TBL] [Abstract][Full Text] [Related]
12. Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation.
Nergärdh A; Nordlander R; Frick M
Clin Cardiol; 2006 Feb; 29(2):56-60. PubMed ID: 16506639
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation.
Alboni P; Razzolini R; Scarfò S; Paparella N; Fucà G; Pedini I; Chioin R
J Am Coll Cardiol; 1993 Nov; 22(5):1373-7. PubMed ID: 8227794
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recent onset atrial fibrillation with intravenous sotalol and/or flecainide.
Peters FP; Braat SH; Heymeriks J; Wellens HJ
Neth J Med; 1998 Sep; 53(3):93-6. PubMed ID: 9803139
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.
Benditt DG; Williams JH; Jin J; Deering TF; Zucker R; Browne K; Chang-Sing P; Singh BN
Am J Cardiol; 1999 Aug; 84(3):270-7. PubMed ID: 10496434
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
[TBL] [Abstract][Full Text] [Related]
17. [Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].
Patten M; Koch HP; Sonntag F; Lüderitz B; Meinertz T
Z Kardiol; 1999 Mar; 88(3):185-94. PubMed ID: 10355069
[TBL] [Abstract][Full Text] [Related]
18. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery.
Sanjuán R; Blasco M; Carbonell N; Jordá A; Núñez J; Martínez-León J; Otero E
Ann Thorac Surg; 2004 Mar; 77(3):838-43. PubMed ID: 14992883
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation.
Dan GA; Gonţa A
Rom J Intern Med; 1997; 35(1-4):19-27. PubMed ID: 9562649
[TBL] [Abstract][Full Text] [Related]
20. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
Trappe HJ; Pfitzner P
Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
